Practical Fragments

This blog is meant to allow Fragment-based Drug Design Practitioners to get together and discuss NON-CONFIDENTIAL issues regarding fragments.

Showing posts with label Roche. Show all posts

Showing posts with label Roche. Show all posts

29 September 2014

FBLD 2014

FBLD 2014 , the fifth in an illustrious series of conferences, took place in Basel, Switzerland last week. Organizers Wolfgang Jahnke ( No...

17 August 2011

First fragment-based drug approved

Today marks history with the first FDA approval of a drug to come out of fragment-based screening. The drug is branded as Zelboraf (vemurafe...

30 April 2010

Fifth Annual Fragment-Based Drug Discovery

The first of two conferences in 2010 exclusively devoted to fragment-based drug discovery concluded in San Diego this week, and I thought ...

06 February 2010

Molecular Medicine Tri-Conference 2010

The first event on our 2010 calendar , the Molecular Medicine Tri-Conference 2010 , was held in San Francisco earlier this week. There were ...

15 October 2009

Genentech’s affinity for Graffinity

Heidelberg-based Graffinity today announced that they would be collaborating with the Genentech division of Roche. Graffinity will apply i...

View web version

Powered by Blogger.